Xeris Biopharma Holdings Raises FY2026 Sales Guidance from $385.000M-$390.000M to $395.000M-$405.000M vs $387.665M Est
Benzinga Newsdesk 1 hour ago
NewsGuidance
Xeris Biopharma Holdings (NASDAQ:XERS) raises FY2026 sales outlook from $385.000 million-$390.000 million to $395.000 million-$405.000 million vs $387.665 million estimate.
Xeris Biopharma Holdings (NASDAQ:XERS) raises FY2026 sales outlook from $385.000 million-$390.000 million to $395.000 million-$405.000 million vs $387.665 million estimate.